Reverse Patent Settlements In The Pharmaceutical Sector: A Comparative Analysis And Road Ahead For India
| dc.Contributor.Advisor | Prof. Rahul Singh | |
| dc.contributor.author | M, Nandakrishna | |
| dc.date.accessioned | 2021-12-07T16:04:05Z | |
| dc.date.available | 2021-12-07T16:04:05Z | |
| dc.date.issued | 2021 | |
| dc.identifier.uri | http://opac.nls.ac.in:8081/xmlui/handle/123456789/872 | |
| dc.publisher | National Law School of Indian University, Bangalore | en_US |
| dc.subject | 1. Competition Law and Intellectual Property Laws, 2. Pharmaceutical patent disputes, 3. Federal Trade Commission, 4. TRIPS. | en_US |
| dc.title | Reverse Patent Settlements In The Pharmaceutical Sector: A Comparative Analysis And Road Ahead For India | en_US |
| dc.type | Thesis | en_US |